Lipid molecules induce p38α activation via a novel molecular switch

Journal of Molecular Biology

Volumn 424, Issue 5, 2012, Pages 339-353

  Tzarum, Netanel ^a   Eisenberg Domovich, Yael ^a   Gills, Joell J ^b   Dennis, Phillip A ^b   Livnah, Oded ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

alternative activation modes; MAP kinase; p38; PIAs; protein structure

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 14; PERIFOSINE; PHOSPHATIDYLINOSITOL; PROTEIN KINASE C;

ARTICLE; AUTOPHOSPHORYLATION; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME MECHANISM; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 84869205005     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2012.10.007     Document Type: Article

References (55)

1. R.L. Eckert, T. Efimova, S. Balasubramanian, J.F. Crish, F. Bone, and S. Dashti p38 mitogen-activated protein kinases on the body surface - a function for p38δ J. Invest. Dermatol. 120 2003 823 828
2. M.C. Hu, Y.P. Wang, A. Mikhail, W.R. Qiu, and T.H. Tan Murine p38-δ mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines J. Biol. Chem. 274 1999 7095 7102
3. Y. Shi, and M. Gaestel In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance Biol. Chem. 383 2002 1519 1536
4. J.C. Lee, J.T. Laydon, P.C. McDonnell, T.F. Gallagher, S. Kumar, and D. Green A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 1994 739 746
5. J. Han, J.D. Lee, L. Bibbs, and R.J. Ulevitch A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265 1994 808 811
6. D. Engelberg Stress-activated protein kinases - tumor suppressors or tumor initiators? Semin. Cancer Biol. 14 2004 271 282
7. R. Haq, and B. Zanke Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance Cancer Metastasis Rev. 17 1998 233 239
8. D.P. Harkin, J.M. Bean, D. Miklos, Y.H. Song, V.B. Truong, and C. Englert Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 97 1999 575 586
9. J.A. Recio, and G. Merlino Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 Oncogene 21 2002 1000 1008
10. A. Clerk, A. Michael, and P.H. Sugden Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes Biochem. J. 333 1998 581 589
11. C.A. Hazzalin, E. Cano, A. Cuenda, M.J. Barratt, P. Cohen, and L.C. Mahadevan p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient Curr. Biol. 6 1996 1028 1031
12. K. Ono, and J. Han The p38 signal transduction pathway: activation and function Cell. Signalling 12 2000 1 13
13. S. Pugazhenthi, T. Boras, D. O'Connor, M.K. Meintzer, K.A. Heidenreich, and J.E. Reusch Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway J. Biol. Chem. 274 1999 2829 2837
14. J. Xing, J.M. Kornhauser, Z. Xia, E.A. Thiele, and M.E. Greenberg Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation Mol. Cell. Biol. 18 1998 1946 1955
15. T. Zarubin, and J. Han Activation and signaling of the p38 MAP kinase pathway Cell Res. 15 2005 11 18
16. B. Ge, H. Gram, F. Di Padova, B. Huang, L. New, and R.J. Ulevitch MAPKK-independent activation of p38α mediated by TAB1-dependent autophosphorylation of p38α Science 295 2002 1291 1294
17. J.M. Salvador, P.R. Mittelstadt, T. Guszczynski, T.D. Copeland, H. Yamaguchi, and E. Appella Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases Nat. Immunol. 6 2005 390 395
18. P.R. Mittelstadt, H. Yamaguchi, E. Appella, and J.D. Ashwell T cell receptor-mediated activation of p38α by mono-phosphorylation of the activation loop results in altered substrate specificity J. Biol. Chem. 284 2009 15469 15474
19. W.L. DeLano The PyMOL Molecular Graphics System 2002 DeLano Scientific San Carlos, CA
20. J.J. Gills, S.S. Castillo, C. Zhang, P.A. Petukhov, R.M. Memmott, and M. Hollingshead Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38α, through MKK3/6-independent and -dependent mechanisms J. Biol. Chem. 282 2007 27020 27029
21. A.P. Kozikowski, H. Sun, J. Brognard, and P.A. Dennis Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt J. Am. Chem. Soc. 125 2003 1144 1145
22. C.C. Thomas, M. Deak, D.R. Alessi, and D.M. van Aalten High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate Curr. Biol. 12 2002 1256 1262
23. S.S. Castillo, J. Brognard, P.A. Petukhov, C. Zhang, J. Tsurutani, and C.A. Granville Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues Cancer Res. 64 2004 2782 2792
24. S.B. Kondapaka, S.S. Singh, G.P. Dasmahapatra, E.A. Sausville, and K.K. Roy Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation Mol. Cancer Ther. 2 2003 1093 1103
25. J.J. Gills, and P.A. Dennis Perifosine: update on a novel Akt inhibitor Curr. Oncol. Rep. 11 2009 102 110
26. K.P. Wilson, M.J. Fitzgibbon, P.R. Caron, J.P. Griffith, W. Chen, and P.G. McCaffrey Crystal structure of p38 mitogen-activated protein kinase J. Biol. Chem. 271 1996 27696 27700
27. F. Zhang, A. Strand, D. Robbins, M.H. Cobb, and E.J. Goldsmith Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution Nature 367 1994 704 711
28. B.J. Canagarajah, A. Khokhlatchev, M.H. Cobb, and E.J. Goldsmith Activation mechanism of the MAP kinase ERK2 by dual phosphorylation Cell 90 1997 859 869
29. Z. Wang, P.C. Harkins, R.J. Ulevitch, J. Han, M.H. Cobb, and E.J. Goldsmith The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution Proc. Natl Acad. Sci. USA 94 1997 2327 2332
30. Y.Y. Zhang, J.W. Wu, and Z.X. Wang Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38α J. Biol. Chem. 286 2011 16150 16162
31. R. Diskin, D. Engelberg, and O. Livnah A novel lipid binding site formed by the MAP kinase insert in p38α J. Mol. Biol. 375 2008 70 79
32. Q.F. Collins, Y. Xiong, E.G. Lupo Jr., H.Y. Liu, and W. Cao p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes J. Biol. Chem. 281 2006 24336 24344
33. A.M. Engelbrecht, P. Engelbrecht, S. Genade, C. Niesler, C. Page, M. Smuts, and A. Lochner Long-chain polyunsaturated fatty acids protect the heart against ischemia/reperfusion-induced injury via a MAPK dependent pathway J. Mol. Cell. Cardiol. 39 2005 940 954
34. J.Y. Kong, S.S. Klassen, and S.W. Rabkin Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis Mol. Cell. Biochem. 278 2005 39 51
35. M.A. Reddy, P.R. Thimmalapura, L. Lanting, J.L. Nadler, S. Fatima, and R. Natarajan The oxidized lipid and lipoxygenase product 12(S)- hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects J. Biol. Chem. 277 2002 9920 9928
36. P.A. Nony, S.B. Kennett, W.C. Glasgow, K. Olden, and J.D. Roberts 15S-Lipoxygenase-2 mediates arachidonic acid-stimulated adhesion of human breast carcinoma cells through the activation of TAK1, MKK6, and p38 MAPK J. Biol. Chem. 280 2005 31413 31419
37. B. Nolen, S. Taylor, and G. Ghosh Regulation of protein kinases; controlling activity through activation segment conformation Mol. Cell 15 2004 661 675
38. N. Tzarum, R. Diskin, D. Engelberg, and O. Livnah Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation J. Mol. Biol. 405 2011 1154 1169
39. L. Jirmanova, D.N. Sarma, D. Jankovic, P.R. Mittelstadt, and J.D. Ashwell Genetic disruption of p38α Tyr323 phosphorylation prevents T-cell receptor-mediated p38α activation and impairs interferon-γ production Blood 113 2009 2229 2237
40. J.J. Perry, R.M. Harris, D. Moiani, A.J. Olson, and J.A. Tainer p38α MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses J. Mol. Biol. 391 2009 1 11
41. L. Tong, S. Pav, D.M. White, S. Rogers, K.M. Crane, and C.L. Cywin A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket Nat. Struct. Biol. 4 1997 311 316
42. O. Hantschel, B. Nagar, S. Guettler, J. Kretzschmar, K. Dorey, J. Kuriyan, and G. Superti-Furga A myristoyl/phosphotyrosine switch regulates c-Abl Cell 112 2003 845 857
43. A.C. Bastidas, M.S. Deal, J.M. Steichen, M.M. Keshwani, Y. Guo, and S.S. Taylor Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase J. Mol. Biol. 422 2012 215 229
44. B. Nagar, O. Hantschel, M.A. Young, K. Scheffzek, D. Veach, and W. Bornmann Structural basis for the autoinhibition of c-Abl tyrosine kinase Cell 112 2003 859 871
45. R. Akella, T.M. Moon, and E.J. Goldsmith Unique MAP kinase binding sites Biochim. Biophys. Acta 1784 2008 48 55
46. D.L. Sheridan, Y. Kong, S.A. Parker, K.N. Dalby, and B.E. Turk Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs J. Biol. Chem. 283 2008 19511 19520
47. R. Diskin, N. Askari, R. Capone, D. Engelberg, and O. Livnah Active mutants of the human p38α mitogen-activated protein kinase J. Biol. Chem. 279 2004 47040 47049
48. R. Diskin, M. Lebendiker, D. Engelberg, and O. Livnah Structures of p38α active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation J. Mol. Biol. 365 2007 66 76
49. R. Diskin, D. Engelberg, and O. Livnah High-resolution diffracting crystals of intrinsically active p38α MAP kinase: a case study for low-throughput approaches Acta Crystallogr., Sect. D: Biol. Crystallogr. 63 2007 260 265
50. E.A. Stura, P. Chen, C.M. Wilmot, J.H. Arevalo, and I.A. Wilson Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2 Proteins 12 1992 24 30
51. Z. Otwinowski, and W. Minor Processing of X-ray Diffraction Data Collected in Oscillation Mode Methods in Enzymology 276 1997 Academic Press New York, NY 307 326
52. A.A. Vagin, and M.N. Isupov Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps Acta Crystallogr., Sect. D: Biol. Crystallogr. 57 2001 1451 1456
53. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr., Sect. D: Biol. Crystallogr. 53 1997 240 255
54. R.J. Morris, A. Perrakis, and V.S. Lamzin ARP/wARP and automatic interpretation of protein electron density maps Methods Enzymol. 374 2003 229 244
55. P. Emsley, and K. Cowtan Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132